| Robert Byron Mitchell, DO | |
|
508 Upland St, Kenai, AK 99611 | |
| (907) 335-7500 | |
| Not Available |
| Full Name | Robert Byron Mitchell |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 508 Upland St, Kenai, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346684313 | NPI | - | NPPES |
| 358545701 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | Q5229 (Texas) | Secondary |
| 207Q00000X | Family Medicine | 141983 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kenaitze Indian Tribe | 4082506225 | 18 |
News Archive
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2012.
Genentech, Inc. today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.
Leading Australian and international medical experts will convene in Brisbane next week to address crucial areas of rehabilitation medicine, including health reform, barriers to rehabilitation healthcare services and pain management.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
› Verified 5 days ago
| Entity Name | Kenaitze Indian Tribe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932114600 PECOS PAC ID: 4082506225 Enrollment ID: O20040325000198 |
News Archive
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2012.
Genentech, Inc. today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.
Leading Australian and international medical experts will convene in Brisbane next week to address crucial areas of rehabilitation medicine, including health reform, barriers to rehabilitation healthcare services and pain management.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Byron Mitchell, DO 508 Upland St, Kenai, AK 99611-8026 Ph: (907) 335-7500 | Robert Byron Mitchell, DO 508 Upland St, Kenai, AK 99611 Ph: (907) 335-7500 |
News Archive
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2012.
Genentech, Inc. today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.
Leading Australian and international medical experts will convene in Brisbane next week to address crucial areas of rehabilitation medicine, including health reform, barriers to rehabilitation healthcare services and pain management.
A new genetic discovery in the field of Huntington's disease (HD) could mean a more effective way in determining severity of this neurological disease when using specific treatments. This study may provide insight for treatments that would be effective in slowing down or postponing the death of neurons for people who carry the HD gene mutation, but who do not yet show symptoms of the disease.
› Verified 5 days ago
Dr. Kim Edward Thiele, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 36901 Mallard Rd, Kenai, AK 99611 Phone: 907-283-5000 Fax: 907-283-5013 | |
Dr. Samuel Herman Schurig, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10543 Kenai Spur Highway, Kenai, AK 99611 Phone: 907-283-9118 Fax: 907-335-2460 | |
Jefferson Wasson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 10543 Kenai Spur Hwy, Kenai, AK 99611 Phone: 360-626-3036 | |
Mr. Ray Lynn Carlson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10543 Kenai Spur Hwy, Kenai, AK 99611 Phone: 907-283-9118 Fax: 907-283-5341 | |
Dr. Ann Kathryn-meyer Hupe, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10543 Kenai Spur Hwy, Kenai, AK 99611 Phone: 907-283-9118 Fax: 907-283-5341 | |
Dr. Terri Lee Elliott, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 135 Bidarka St, Suite 101, Kenai, AK 99611 Phone: 907-335-0034 Fax: 907-335-0064 |